BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10667582)

  • 21. Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps.
    Hautmann S; Huland E; Wullbrand A; Friedrich M; Huland H
    Anticancer Res; 2000; 20(6B):4495-8. PubMed ID: 11205294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR-3) with a reconstituted basement membrane (Matrigel).
    Kanemoto T; Martin GR; Hamilton TC; Fridman R
    Invasion Metastasis; 1991; 11(2):84-92. PubMed ID: 1917387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice.
    Livant DL; Brabec RK; Kurachi K; Allen DL; Wu Y; Haaseth R; Andrews P; Ethier SP; Markwart S
    J Clin Invest; 2000 Jun; 105(11):1537-45. PubMed ID: 10841512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential.
    Tian B; Li Y; Ji XN; Chen J; Xue Q; Ye SL; Liu YK; Tang ZY
    J Cancer Res Clin Oncol; 2005 Feb; 131(2):80-6. PubMed ID: 15480781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of anti-cell adhesive synthetic Arg-Gly-Asp-Ser analogue and anticancer drug doxorubicin heightens their original antimetastatic activities.
    Komazawa H; Fujii H; Kojima M; Mori H; Ono M; Itoh I; Azuma I; Saiki I
    Oncol Res; 1995; 7(7-8):341-51. PubMed ID: 8747597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenesis inhibitor TNP-470 inhibits growth and metastasis of a hormone-independent rat prostatic carcinoma cell line.
    Miki T; Nonomura N; Nozawa M; Harada Y; Nishimura K; Kojima Y; Takahara S; Okuyama A
    J Urol; 1998 Jul; 160(1):210-3. PubMed ID: 9628652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo.
    Nierodzik ML; Klepfish A; Karpatkin S
    Thromb Haemost; 1995 Jul; 74(1):282-90. PubMed ID: 8578473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.
    Chen B; Pogue BW; Zhou X; O'Hara JA; Solban N; Demidenko E; Hoopes PJ; Hasan T
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):720-7. PubMed ID: 15701861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 9-Aminocamptothecin: a topoisomerase I inhibitor with preclinical activity in prostate cancer.
    de Souza PL; Cooper MR; Imondi AR; Myers CE
    Clin Cancer Res; 1997 Feb; 3(2):287-94. PubMed ID: 9815685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of rat prostate and lung tumors to ionizing radiation combined with the angiogenesis inhibitor AMCA.
    Kal HB; Struikmans H; Gebbink MF; Voest EE
    Strahlenther Onkol; 2004 Dec; 180(12):798-804. PubMed ID: 15592700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The laminin-derived peptide YIGSR (Tyr-Ile-Gly-Ser-Arg) inhibits human pre-B leukaemic cell growth and dissemination to organs in SCID mice.
    Yoshida N; Ishii E; Nomizu M; Yamada Y; Mohri S; Kinukawa N; Matsuzaki A; Oshima K; Hara T; Miyazaki S
    Br J Cancer; 1999 Aug; 80(12):1898-904. PubMed ID: 10471037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.
    Littlepage LE; Sternlicht MD; Rougier N; Phillips J; Gallo E; Yu Y; Williams K; Brenot A; Gordon JI; Werb Z
    Cancer Res; 2010 Mar; 70(6):2224-34. PubMed ID: 20215503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis.
    Yi M; Ruoslahti E
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):620-4. PubMed ID: 11209058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Participation of syndecan 2 in the induction of stress fiber formation in cooperation with integrin alpha5beta1: structural characteristics of heparan sulfate chains with avidity to COOH-terminal heparin-binding domain of fibronectin.
    Kusano Y; Oguri K; Nagayasu Y; Munesue S; Ishihara M; Saiki I; Yonekura H; Yamamoto H; Okayama M
    Exp Cell Res; 2000 May; 256(2):434-44. PubMed ID: 10772816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.
    Zhu H; Liu XW; Cai TY; Cao J; Tu CX; Lu W; He QJ; Yang B
    J Pharmacol Exp Ther; 2010 Aug; 334(2):489-99. PubMed ID: 20472666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition.
    Su B; Zheng Q; Vaughan MM; Bu Y; Gelman IH
    Cancer Res; 2006 Jun; 66(11):5599-607. PubMed ID: 16740695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
    Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
    Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
    Eccles SA; Box GM; Court WJ; Bone EA; Thomas W; Brown PD
    Cancer Res; 1996 Jun; 56(12):2815-22. PubMed ID: 8665519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer.
    Howard EW; Ling MT; Chua CW; Cheung HW; Wang X; Wong YC
    Clin Cancer Res; 2007 Mar; 13(6):1847-56. PubMed ID: 17363541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.